Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Health Canada Approves ELAHERE® for Certain Types of Platinum-Resistant Ovarian Cancers Pharmaceutical Investing
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications Biotech Investing
AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS Biotech Investing
FDA Clears MiniMed 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes Medical Device Investing
Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board Biotech Investing
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Pharmaceutical Investing
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis , Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI Biotech Investing
